Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland

AIM: The aim of this study was to assess the cost effectiveness of the Pill Protect (PP) genetic screening test for venous thromboembolism (VTE) risk compared with standard of care (SoC), for women considering combined hormonal contraceptives (CHCs) in Switzerland. METHODS: A two-part microsimulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sutherland, C Simone, Ademi, Zanfina, Michaud, Joëlle, Schur, Nadine, Lingg, Myriam, Bhadhuri, Arjun, Pache, Thierry D., Bitzer, Johannes, Suchon, Pierre, Albert, Valerie, Hersberger, Kurt E., Tanackovic, Goranka, Schwenkglenks, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858234/
https://www.ncbi.nlm.nih.gov/pubmed/31699733
http://dx.doi.org/10.1136/bmjopen-2019-031325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858234/
https://www.ncbi.nlm.nih.gov/pubmed/31699733
http://dx.doi.org/10.1136/bmjopen-2019-031325

Ejemplares similares